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Cardiopulmonary bypass (CPB) has been used in veterinary medicine in exper-
imental surgery and to address congenital and acquired diseases. We review the
veterinary literature and expose common challenges of CPB in dogs and cats.
Specifically, we describe the most specific elements of this technique in veterinary
patients. The variety in animal size has made it difficult to standardize cannulation
techniques, oxygenators, and priming volumes and solutions. The fact that one of
the most common cardiovascular disorders, mitral valve disease, occurs predomi-
nantly in small dogs has limited the use of bypass in these patients because of the
need for small, low prime oxygenators and pumps that have been unavailable until
recently. Coagulation, hemostasis, and blood product availability have also repre-
sented important factors in the way CPB has developed over the years. The cost
and the challenges in operating the bypass machine have represented substantial
limitations in its broader use.
Cardiopulmonary bypass (CPB) has been used inconsis-
tently since the late 1960s in veterinary medicine to repair
some of the most common intracardiac conditions that oc-
cur in dogs and cats.1–8 In animals, heart surgery has been
performed in experimental settings and to address con-
genital and acquired conditions, such as ventricular septal
defects,9, 10 double chamber right ventricle,11 Tetralogy of
Fallot,12, 13 and mitral valve disease.14–16 When performing
CPB in dogs and cats, there are important factors to con-
sider: the different anatomy of the thoracic cavities requir-
ing different types of cannulation, the dramatic variability
in size and body conformation, the limited blood volume in
small patients, the difference in coagulation and hemosta-
sis compared with human patients, the limited availabil-
ity of blood products, and the cost associated with their
use.
We provide an overview of the literature related to
the use of CPB for cardiac surgery in domestic animals.
The data are extrapolated from the veterinary literature
looking at cases where CPB was used to perform cardiac
surgery.
ANATOMY
The thoracic cavity in domestic species resembles a trun-
cated cone. The laterolateral compression in dogs and the
anteroposterior compression in man and primates deter-
Presented in part at the ACVS Symposium, Seattle, WA, Octo-
ber 2010.
mine several differences in the general surgical approach to
the thoracic cavity. In dogs, the heart is located between the
planes of the 3rd and 6th intercostal spaces. The cardiac axis
is inclined craniodorsally with the apex of the heart mildly
to the left. Variations in the position of the heart within
the thoracic cavity (Fig 1) are observed in different species
and breeds or at different ages. For example, among dogs,
the heart tends to be more vertical in the Doberman Pin-
scher, and it becomes progressively more horizontal in cats
as they age. In addition to these considerations, the diseased
heart can assume unusual inclinations and occupy differ-
ent sections of the thoracic cavity because of enlargement
of various cardiac chambers or secondary to generalized
cardiomegaly.
To understand the anatomic challenges unique to ani-
mals, a review of the cardiac anatomy and associated tho-
racic structures is provided to facilitate orientation and
identification of these details. Most of the cardiac surface
is covered by the lungs except at the level of the cardiac
notch (4th and 5th intercostal spaces), on the right side.
On the surface of the heart, the coronary groove defines
the separation between atria and ventricles, but it is ab-
sent at the level of the right ventricle.17 The Waterston’s
groove represents the embryologic separation between the
left and the right atria.18 The interventricular grooves (si-
nusoidal and paraconal) are not obvious in small animals
as they are in other mammals.17 However, the paraconal
groove has an oblique direction on the cranioventral sur-
face and the subsinusoidal groove delineates the separation
of the ventricles on the caudodorsal surface. The coronary
arteries run within the grooves. The left coronary artery is
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Figure 1 Variations in the position of the heart within the thoracic
cavity are observed in different species and breeds or at different ages.
The normal cardiac silhouette and position within the thoracic cavity (A)
can appear altered in specific breeds, such as Doberman Pinscher (B);
it also becomes progressively more horizontal in cats as they age (C),
and it assumes unusual inclinations and occupies different sections of
the thoracic cavity because of enlargement of various cardiac chambers
or secondary to generalized cardiomegaly (D). (Courtesy of Drs. Nathan
Nelson and Joana Coelho).
usually the predominant one and gives off the paraconal
interventricular branch (runs toward the apex in the para-
conal interventricular groove) and the circumflex branch
(runs on the caudal surface and ends as the subsinusoidal
interventricular branch). The right coronary artery runs in
a circumflex groove between the right atrium and ventricle.
The venous system is satellite of the arterial system with the
vessels draining into the coronary sinus and into the right
atrium.17
The aorta originates from the fibrous cardiac skeleton,
arises cranially toward the left as the aortic arch and as-
cending aorta and then curves dorsocaudally to form the
descending aorta. The first branch of the aortic arch is the
brachiocephalic trunk, which gives off the common carotid
arteries and the right subclavian artery in dogs and cats.
The second branch is the left subclavian artery. The main
pulmonary artery lies on the left side of the thoracic cavity
and it branches into left pulmonary artery (smaller) and
right (larger branch, leaving the main pulmonary artery
with 90◦ angle, lying between the venae cavae). The cranial
and caudal venae cavae lie to the right of the midline and
enter the right atrium. The right azygous vein runs dorsally
and enters the cranial vena cava before its termination. The
left and right vagus nerves run at the level of the heart
base, while the left and right phrenic nerves run over the
pericardium at the level of the coronary groove. The left
recurrent nerve originates from the left vagus at the level
of the ductus or ligamentum arteriosum while the right re-
current nerve leaves the right vagus in the proximity of the
right subclavian.17
In dogs, observation of the heart base structures is
extremely limited from a median sternotomy. The left
atrium can be approached from both a left and a right
thoracotomy. Depending on the disease presentation, the
approach may need to be modified. For example, in an
infundibular type of stenosis or when the pulmonic steno-
sis has induced severe right ventricular hypertrophy, a me-
dian sternotomy rather than a left lateral approach may
be necessary to obtain a complete observation of the right
outflow tract. The femoral vessels are very superficial and
easily approachable, while the approach to the carotid
artery requires dissecting in a plane dorsal to the jugular
vein, just adjacent to the trachea. The size of these ves-
sels can affect the type of cannulae used; Table 1 shows
the size of arterial and venous cannulae in relation to
weight.
Table 1 Arterial and Venous Cannulae Used Based on Body Weight
Arterial Venous References
<10 kg 6–8 Fr (2–2.5 mm) left or right carotid 8–10 Fr (2.5–3.3 mm) Kanemoto et al2
10 Fr (3.3 mm) straight carotid 12 Fr (4 mm) cranial; 14 Fr (4.7 mm) caudal VC Brourman et al29
6 Fr (2 mm) carotid 14 Fr (4.7 mm) cranial; 12 Fr (4 mm) caudal VC Soda et al6
10 Fr (3.3 mm) left carotid 20 Fr (6.7 mm) single atrial Boggs et al58
1 mm (3 Fr) femoral NA Rosenkrantz et al57
2.5 mm (7.5 mm) left femoral 14 Fr (4.7 mm)16 Fr (5.3 mm) (bicaval) Shimizu et al68
1.0–3.0 mm (3–9 Fr) femoral artery NA Tanaka et al3
2-mm (6 Fr) angled left femoral 8 mm (24 Fr) straight Borenstein et al5
10–12 Fr (3.3–4.0 mm) carotid 16 Fr (5.3 mm) bicaval Pullen et al69
10–14 G left external iliac 28–32 G Lew et al27
10–20 kg 8–12 Fr (2.5–4 mm) left femoral NA Orton et al12
8 mm (24 Fr) root aorta NA Cook et al41
NA 18–24 Fr (6–8 mm) Takashima et al14
4 mm (12 Fr) aortic 36 Fr (12 mm) single atrial Liam et al32
>21 kg 14 Fr (4.7 mm) left femoral Rohn et al55
20–22 Fr (6.7–7.3 mm) left femoral 36–40 Fr (12–13.3 mm) single atrial Klement et al66
16–20 Fr (5.3–6.7 mm) left femoral 32–40 Fr (10.7–13.3 mm) Klement et al33
VC, vena cava; NA, not available.
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Figure 2 The cardiac structures from a left lateral thoracotomy. Lungs
and other thoracic structures have been removed.
Figure 3 The cardiac structures seen through a right lateral thoraco-
tomy. Lungs and other thoracic structures have been removed.
CANNULATION
In people, most procedures are performed from a median
sternotomy with direct aortic cannulation for arterial ac-
cess, and venous bicaval or single atrial cannulation.19 His-
torically, in domestic animals, left and right lateral thora-
cotomies (Figs 2, 3) have been used more frequently than
median sternotomy. Because of limited exposure and the
surgical approaches necessary in different procedures, the
cannulation has also been very variable. Arterial cannula-
tion, independent of the surgical approach or the procedure,
is primarily done through either the femoral or the carotid
artery, while venous cannulation varies depending on the
surgical approach (Table 2).
The arterial cannula represents the narrowest part of
the extracorporeal circuit. High flow through the arterial
cannula can lead to high-pressure gradients, high veloc-
ity flow, cavitation, and turbulence.19 Pressure gradients
>100 mmHg are associated with hemolysis and protein
denaturation.19 The jetting effect of small cannulae may
cause damage to the interior aortic wall and/or aortic dis-
section. Several types of arterial cannulae have been evalu-
ated to result in lower pressure gradients. The use of femoral
artery cannulation is possible when aortic cannulation is ill
advised. However, because of smaller size vessels, optimal
flow may be compromised because of high-pressure gra-
dients. This shortcoming can be palliated by using smaller
and less-optimal cannulae. Vascular distal ischemia and ret-
rograde dissection of the aorta are reported complications
associated with femoral artery cannulation.19 Femoral ar-
terial cannulation (Fig 4) can simplify the surgical field by
decreasing the amount of instrumentation; however, the
size of this vessel in domestic animals can limit the perfu-
sion flow. Aortic cannulation (Fig 5) has been rarely used in
dogs because of space limitation, difficulty in approaching
the aortic arch from some thoracotomies in animals (right
thoracotomy), and the anecdotal report of being more frag-
ile than the human aorta. The aorta appears to be me-
chanically fragile when a cannula is inserted, but we lack
histologic data to confirm something that appears to be
anecdotal information. The aortic wall of dogs and mam-
mals in general consists of the intimal, medial, and adven-
titial layers with the medial layer being the thickest.20 The
aortic media is composed of concentric layers of uniform
composition bounded by thick elastin lamellae.21 In mam-
mals, the elastic laminae are well defined and the gap be-
tween them is usually filled by a single smooth muscle cell.22
Wolinsky et al investigated the relations among aortic thick-
ness, medial thickness, medial architecture, and vessel wall
tension in a comparative study of adult thoracic aortic wall
in mammals.21 However, definitive conclusive data regard-
ing fragility of the canine aorta cannot be extrapolated from
this manuscript and further studies should be conducted.
Table 2 Reported Cannulation Types by Approach (Number of Veterinary Publications Where a Specific Type of Cannulation Is Reported)
Approach (no. of publications) Venous Arterial
Single atrial Bicaval Jugular/ NS Aorta Right Left Any Carotid NS or
femoral femoral femoral femoral other
S D NS
Left thoracotomy (12) 2 2 5 0 2 1 2 0 5 2 3
Right thoracotomy (13) 1 10 3 5 3 3 2
Median sternotomy (19) 3 13 3 3 4 2 2 5 3
Not specified (4) 1 3 1 2 1 1
S, single stage; D, dual stage; NS, not specified.
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Figure 4 A peripheral arterial vessel (carotid or femoral artery) is easily
approached and dissected. The adventitia is removed and the vessel
is exposed. The vessel is distally ligated. While maintaining temporary
proximal occlusion via silk suture or silastic tape, and transverse or
longitudinal incision with an 11 blade is performed in the upper portion
of the vessel (A). Dilation of the incision is obtained by using a vessel
dilator or a forceps (B). The arterial cannula is introduced inside the
lumen aiming toward the proximal portion of the vessel (C, D). The
cannula is secured in placed by applying a red rubber tourniquet to the
proximal suture and ligating the vessel to the tourniquets using silk
suture (E).
Figure 5 The aortic arch with the brachiocephalic trunk and the left
subclavian artery are shown from a left-side window while applying a
double purse string suture lines for aortic cannulation (A). A stabbed
incision is performed with an 11 blade (B, C); an arterial cannula is
introduced within the lumen, paying attention to avoid dissection of
the vessel and proper placement to perfuse the cranial and caudal
compartments (D).
CPB FLOW AND HYPOTHERMIA
In the reviewed literature, the average CPB flow, inde-
pendent of weight and thermic conditions, is 77.1 ± 22.9
mL/kg/min.
The first use of hypothermia is reported in the late
1950s where in experimental dogs it was used to inves-
tigate survival factors in hypothermic conditions.22 Hy-
pothermia is used to provide organ and myocardial pro-
tection, minimize cell trauma, and reduce pump flow.23
By lowering the temperature of the blood, the metabolic
rate and oxygen consumption is reduced along with preser-
vation of cell membranes. Hypothermia helps to preserve
phosphate stores and reduces neurotransmitter release.23
By reducing neurotransmitter release during ischemia, the
opening of calcium channels and subsequent activation of
destructive enzymatic systems would by attenuated, thus
reducing calcium entry into the cell and restricting cell
membrane permeability.23 Respiratory physiology is partic-
ularly affected by lowering body temperature. Compared to
normothermic conditions, the solubility of gases increases,
while the content of the gas in a solution remains con-
stant. Therefore, the partial pressure of gases dissolved in
the blood is also decreased making more oxygen available.
The oxygen–hemoglobin dissociation curve undergoes a left
shift resulting in more oxygen being released in tissues at a
lower partial pressure.23 The production of carbon dioxide
decreases but the solubility increases. Therefore, in associa-
tion with hypoventilation, the high level of carbon dioxide
causes decreases in pH. Metabolic acidosis develops partic-
ularly after discontinuation of bypass because the lactic acid
is carried from the periphery to the general circulation.24
The heart rate decreases to approximately half the normoth-
ermic baseline at 25◦C.24 In the electrocardiogram (ECG), a
prolongation of PR interval, widening of the QRS, changes
in ST and T wave are observed. Cardiac output and arterial
pressure are also decreased to ∼33% of the normothermic
conditions.24
Therefore in dogs, the major advantage of maintain-
ing hypothermic conditions is the reduction in metabolic
needs that allows a reduction of flow from 100 mL/kg/min
to 30 mL/kg/min with deep hypothermia.25 However, hy-
pothermia can induce several effects on the management
of bypass. The metabolic rate and oxygen consumption
are decreased with hypothermia, and the release of excita-
tory neurotransmitters is also reduced.26 Compared to nor-
mothermic perfusion, hypothermia allows better myocar-
dial protection, lower flows, less blood trauma, and better
organ perfusion. Therefore, mild-to-moderate hypothermia
(>25◦C) is commonly used in human patients undergoing
surgery.26
Occasionally, deep hypothermic arrest is induced in
surgeries involving the aorta and the cerebral vessels and
in some complex congenital repairs in pediatric patients.26
Hypothermia can be detrimental if used without bypass
because of the difficulty in re-warming which is eas-
ily and quickly done with bypass. Three approaches to
4 Vete inary Su gery 0  (20 2) 1–18  C
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hypothermia can be used under CPB: blood-cooling,
cold cardioplegic coronary perfusion, and/or surface
hypothermia.26 Small dogs were maintained for 45 min-
utes at 15–18◦C with a flow of 20 mL/kg/min,27 and
the pump flow reached the lowest flow rate of 29.2
mL/kg/min in a different group of small dogs at 21.4◦C.2
In this series, slow cooling and quick re-warming seemed
to be the key to successful management. The mean ±
SD temperature reported during CPB is 29.5 ± 4.7◦C.
Shibazaki et al looked at the hemodynamic changes un-
der normothermic and hypothermic conditions in dogs
and they had a mean temperature of 26.57 ± 0.65◦C in
the hypothermic group and 36.00 ± 0.26◦C in the nor-
mothermic group.28 The lowest reported temperature was
documented by Lew et al with values between 15 and
18◦C.27
SMALL PATIENTS
Small patients present a challenge because of their limited
blood volume, risk of hemodilution, and electrolyte dis-
turbances, the small vessels for cannulation, and the need
for very small circuits. There is limited experience in oper-
ating on small veterinary patients. Under normothermic
conditions, the high flow rate may be maintained with
difficulty using very small cannulae and tubing. To date,
CPB has been successfully performed in cats29 and small
dogs in experimental settings under deep hypothermic low
flow CPB.27 CPB has been used in clinical cases using sur-
face hypothermia (weight <5.5 kg),2 and under moderate
hypothermia to repair pulmonic stenosis (weight: 4.7 ±
0.7 kg).3
LIMITED BLOOD VOLUME
Limited blood volume is a major concern in veterinary pa-
tients undergoing cardiac surgery. It is related to patient size,
limited availability of blood products and possible blood
transfusion reaction even with cross-match. Blood volume
in dogs is estimated to be 10% of body weight. Gibson et
al in a study preceding the discovery of CPB by Gibson
himself, looked at the total blood volume in dogs between
5 and 30 kg.30 The minimum volume of 84 mL/kg and
the maximum volume of 97.3 mL/kg correlated with the
minimum and maximum weight, respectively. Most cardiac
conditions with potential for surgical treatment occur in
dogs weighing <15 kg and more likely between 5 and 10
kg. With this small size, hemodilution becomes a concern
when the priming volume approaches the circulating vol-
ume. A safe limit of hemodilution during normothermic
CPB in dogs with a flow rate of 80 mL/kg/min was found
to be higher than 20%.31 Both oxygen delivery and whole
body oxygen uptake decrease when the hematocrit values
are below 18%.32 The formula to estimate the postdilutional
Table 3 Reported Hematocrit
Hematocrit References
22% Akiyama et al70
20% Kanemoto et al2
23–30% Klement and colleagues33,66
28%∗ Lew et al13
18–20% Lew et al27
>25% Monnet et al8
30% Rosenkratz et al57
18%∗ Tanaka et al3
∗Indicates post bypass.
hematocrit (Hct), if nonhemic prime is used, is:
CPB Hct = Hctb × BV/TPV
Hctb is the baseline Hct, BV is the patient’s blood volume,
and the TPV is the total priming volume (priming circuit
+ dog’s volume). Table 3 shows the hematocrit reported in
veterinary publications. Hematocrit was significantly lower
if compared to baseline values, from 42% to 29% in nor-
mal dogs undergoing hypothermic (27◦C) CPB with cardiac
arrest.33
A feasible, advantageous CPB set up in small patients
is obtained by using roller pumps (Fig 6), by minimizing
the circuit with the reduction of length and diameter of
the tubing, and by using low volume bubble traps and
pediatric oxygenators. Centrifugal pumps offer several
advantages over roller pumps including decreased trauma
to the blood, no possibility of excessive line pressure and
tubing disruption, less risk for air emboli, less cavitation,
and no tubing wear or spallation caused by rollers on the
pump head.21 However, roller pumps remain commonly
used in human pediatric cardiac surgery due their higher
accuracy (compared to centrifugal pumps) in delivering
precise volumes at low flow rates.34 The low flow limita-
tion of the centrifugal pump is ∼800 mL/min. A roller
pump can deliver rates as low as 100 mL/min.34 For a
patient weighing 2 kg whose calculated flow rate is 400
mL/min, using a delivery rate of 200 mL/kg/min, the
use of a centrifugal pump would have unreliable flow
rates and possible retrograde flow at low rates. Other
advantages of roller pumps are the lower cost, easy to
sterilize, and variable stroke volumes for different size
patients.34 Small dogs can suffer significant hemodilution
with a large priming volume in the circuit. Reducing the
internal diameter of the tubing and mobilizing the pump
heads can dramatically affect the priming volume. Infant
oxygenators meet most of the requirements needed to
bypass medium and small dogs. Terumo BabyRx (Terumo
Cardiovascular Systems Corporation, Ann Arbor, MI), as
an example, has a very low priming volume (43 mL). Its
use decreases hemodilution. Larger oxygenators (Terumo
Sx10 or RX 15) can provide higher flow (between 2.09
and 5.0 L/min) necessary to bypass larger dogs. (Terumo
cardiovascular products. CAPIOX RX Oxygenators
500 2 –18  C Copyright 201  by The American College of Veterina y Surgeons
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The smallest priming volume of the circuit including
the oxygenator reported in veterinary medicine is 225 mL in
toy breeds,2 260 mL for small breeds,2 and 150 mL in cats.29
Reduction in prime can also be obtained by using vacuum-
assisted venous drainage which allows use of smaller diam-
eter venous lines, and positioning of the reservoir closer to
the field and the patient.35
To counteract hemodilution in dogs (and cats), the ad-
dition of donor’s blood can be contemplated. If blood is
needed, the volume of blood added to the patient is deter-
mined by the following formula:
V = [(Hctd × TPV) − (Hctb × BV)]/Hctt
V (volume required in the prime), Hctd is the desired hema-
tocrit on CPB, Hctb the patient’s hematocrit before CPB,
Hctt hematocrit of donor blood, BV is the patient’s blood
volume, and the TPV is the total priming volume (priming
circuit + dog’s volume).27
In a veterinary case series, the use of sanguineous prim-
ing solution did not result in any side effects but instead
helped to attenuate the decline in hematocrit.2 Most refer-
ral institutions practicing open heart surgery can rely on
readily available blood products. Use of autologous trans-
fusions during or post CPB has been advocated as a way
to reduce the need for postoperative blood products36 and
could be a solution for hemodilution in veterinary medicine.
However, priming the bypass circuit without using blood so-
lutions is currently recommended because of the decrease
in cardiac index, higher pulmonary resistance, and higher
levels of inflammatory cytokines seen when sanguineous
solutions are implemented.37 Moreover, the administration
of blood products in the priming solution has been as-
sociated in people and dogs with a syndrome of arterial
hypotension, portal hypertension and metabolic acidosis.36
Reactions to homologous transfusion can occur in dogs
and cats. In dogs, there are 7 known blood groups and
one newly recognized antigen (DAL) whose clinical signifi-
cance has not been fully investigated. If proper cross-match
and pretransfusion screening procedures are followed, the
problem in dogs will most likely occur in patients previously
sensitized.38 Cats are considered to have 3 blood groups and
the incompatibility can be extremely high. Cats have natu-
rally occurring antibodies which are responsible for the high
incompatibility, and the potentially life-threatening trans-
fusion reactions even without being previously sensitized.39
Therefore, minimizing the use of blood products during or
after heart surgery is probably the safest measure.
Different nonblood priming solutions based on 3 dif-
ferent crystalloid solutions (2.5% dextrose in electrolyte so-
lution, Normosol R (Hospira, Inc., Lake Park, IL), and
Plasma-Lyte 148 (Baxter, Deerfield, IL) were tested in dogs
to evaluate the efficacy and side effects, if used in substitu-
tion to sanguineous solutions. In this study, no difference
was found when these solutions were substituted to blood
priming.36 Priming solutions contain different electrolytes,
buffers (sodium bicarbonate), glucose, heparin, and low
concentration of calcium to avoid the iodizing effect of
calcium during ischemic arrest.37 The veterinary literature
suggests that crystalloid priming solutions are used more
frequently than their sanguineous counterparts.
BLOOD TRAUMA
The ideal oxygenator should have a minimal priming vol-
ume and should induce minimal blood damage while ex-
changing oxygen and removing carbon dioxide from the
body.40 The membrane oxygenator (Fig 7A), resembles in
functionality and design a physiologic lung, more than any
other oxygenator. However, despite this resemblance, it still
has a smaller surface area and limited capacity compared
to the lung. The maximum oxygen transfer of the artificial
lung is <25% the normal lung.40 Most veterinary studies
used membrane oxygenators in the bypass circuit (21/33 re-
ports, providing this information). Bubble oxygenators are
currently still used in a few centers for procedures requiring
short periods of CPB. The simplicity of use and reduced
expense are definitely reasons why the bubble oxygenator
has not been completely abandoned despite the increased
cellular damage. In fact, disc and bubble oxygenators (Fig
7B) are direct contact oxygenators where the bubbles are
in direct contact with the blood, increasing the trauma to
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Figure 7 Membrane oxygenator (A) and bubble oxygenator (B; cour-
tesy of Mike Brigham-Terumo Cardiovascular Systems).
the red blood cells.40 Bubble oxygenators (Temptrol and
Shiley) were found in the older veterinary reports although
the most recent publication with their use was 1997.41 Disc
oxygenators were used only in 2/33 studies.42, 43
Hemolysis can also be produced by other parts of the
circuit and varies with different types of pumps, different
flow rates, and different pressure. Some of these effects only
occur during the procedure and others persist after discon-
tinuation of bypass.44 Several factors determine mechanical
damage to the red blood cells during CPB: positive pres-
sure, wall impact forces, blood flowing on nonendothelial
surfaces, application of negative pressure if applied, blood–
air interface, and shear forces.45–47 Shear forces are partic-
ularly detrimental on RBC survival, in particular when the
forces are applied for long periods. The magnitude varies
in the different parts of the circuit: throughout the arterial
side, the shear forces are high but short in duration, while
on the venous side, the magnitude is lower but the duration
is higher.48
There is very little experience with centrifugal pump
effects in animals because of the paucity of cases in which it
has been used and the limitation to experimental settings.49
Centrifugal pumps have been shown to produce less hemol-
ysis and platelet activation than roller pumps. However,
management of these pumps is more challenging and they
are normally preferred for high volume flows and low
pressures.34 When using roller pumps, the CPB effects on
blood cells and coagulation can be divided into different
categories: the direct effect of the pump inducing mechan-
ical damage on the blood’s components, the activation of
the coagulation pathways, the inflammatory response, and
the indirect effect induced by the administration of anti-
coagulants. Therefore, the many advantages of using roller
pumps in veterinary medicine are tempered by the major
disadvantage of inducing more blood damage compared to
the centrifugal pumps.
CARDIAC ARREST AND MYOCARDIAL PROTEC-
TION
Few cases of beating heart surgery are reported in the vet-
erinary literature.4–6, 16 The major risk of operating with
beating heart is the formation of fatal air embolism during
the procedure. Procedures on the right side can be safely
done without cardiac arrest as long as intracardiac com-
munications are not present. Operations on the left side
require arresting the heart by using aortic cross-clamping
and administration of a high potassium crystalloid solu-
tion, called cardioplegia. The term comes from the Greek
and means arrest of the heart. The sole use of potassium
in the solution could potentially result in poor myocar-
dial protection.23 Therefore, several different solutions are
available and can be chosen to reduce the consequences of
reperfusion injury. A summary of the most common solu-
tions used in veterinary patients is illustrated in Table 4.
Using cardioplegia solutions adds an additional level
of complexity to the procedure and specific strategic plans
have to be made during the procedure, depending on the
approach and the surgery performed. Cardiac arrest is in-
duced by administrating potassium in a concentration rang-
ing from 10 to 40 mmol/L.23 The solutions are described
as intracellular (low sodium and calcium concentration)
and extracellular (higher concentrations of sodium, cal-
cium, and the addition of magnesium). They can be used
in a crystalloid form or in a mixture with a proportion
of 4:1 crystalloid to sanguineous solution. The theoretical
advantages of using sanguineous solutions are the buffer-
ing capability, the oxygen carrying capacity, similarity in
electrolyte composition, and the presence of free radical
scavenging ability in the sanguineous solution.23 However,
the formulation tends to be more complex and there is lack
of evidence to prove physiologic benefits of a sanguineous
solution in the animal model.7 The most common deliv-
ery routes are either antegrade through the aortic root or
retrograde into the coronary sinus. Controversy exists in
people on the administration of “cold” (∼4◦C), “warm”
(34–35◦C), or “tepid” (both warm and cold) cardioplegia.23
Table 4 shows the reported temperature of the cardiople-
gia solutions used in the veterinary literature. The solution
can also be administrated intermittently or continuously.
Although the advantage of one over the other cannot be
investigated in veterinary patients for the lack of reported
use of continuous administration, it appears that contin-
uous delivery can result in better myocardial performance
after bypass in people.40
COAGULATION
Anticoagulation during bypass is normally achieved in peo-
ple and veterinary surgery with heparin given intravenously.
Heparin has been widely used in veterinary medicine in
various settings. It is therefore surprising that the literature
regarding its use lacks scientific evidence and consensus.
126 Veterinary Surgery 42 (2013) 119–136 © Copyright 2012 by The American College of Veterinary Surgeons
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The dose of heparin normally given to people is 300 U/kg
intravenously before cannulation to achieve an activated
clotting time (ACT) reading of >480 seconds.50 Coating
the circuit (3 U/mL in the solution) can decrease the dose
of intravenous heparin needed.50 Throughout the veteri-
nary literature, the doses used are variable and there is no
reference to their rationale (Table 5). Also lacking is a ref-
erence regarding the best way to monitor coagulation in
this setting. When laboratory assessment of coagulation is
available, ACT is not commonly a routine screening test
in patients with coagulopathy because (activated partial
thromboplastin time) aPTT is more sensitive. ACT is used
in human medicine because it provides point-of-care mon-
itoring during bypass. However, in children, ACT does not
correlate to plasma level of heparin.51 Furthermore, ACT
can be affected by hemodilution and hypothermia which
can make the interpretation of the results more challenging
especially in pediatric patients and in small dogs.51 The ex-
pected range of ACT during CPB has not been established
in veterinary patients and different bedside tests may result
in variable accuracy and sensitivity in monitoring heparin
response during CPB. When postoperative bleeding occurs,
it could be because of an incomplete reversal of heparin
or to a different mechanism, including platelets activation,
inflammatory pathways, or hemodilution. CPB creates a
procoagulable state by causing platelet activation and in-
flammation leading to platelet dysfunction and depletion,44
which is believed to be a major component of postopera-
tive bleeding in human patients. Routine ACT tests can-
not distinguish between prolonged blood clotting because
of heparin effect or acquired abnormalities of the coagu-
lation system after a loading dose of heparin for bypass.
Heparinase ACT testing may assist and be used to ascer-
tain whether or not more protamine needs to be given to
adequately reverse the effect of heparin.52 In dogs, it was
hypothesized that using continuous infusion with dypiri-
damole could be responsible for decreasing the incidence of
postoperative bleeding after heart surgery.32 Heparin is nor-
mally reversed with protamine. Protamine administration
can induce severe side effects (hypotension and pulmonary
vasoconstriction) in up to 70% of dogs previously treated
with heparin and receiving an infusion of 2.5 mg/kg.53 The
adverse reactions are minimized in dogs when protamine
is administered via cephalic vein slowly (5 mg/min).53 The
effect of protamine is unknown in cats because of the lim-
ited studies available. Brourman et al reported high ACT
reading after administration of protamine. They indicated
this finding as the possible result of incomplete reversal
in cats or the result of protamine-derived anticoagulant
effect.29
PHYSIOLOGIC AND PATHOLOGIC FINDINGS DUR-
ING AND AFTER BYPASS
The complete list of the most common complications asso-
ciated with CPB is summarized in Tables 6 and 7. Duration
of bypass and aortic cross-clamping are important factors
to consider in the overall incidence of complications. From
the information reported, the mean CPB time is 92.4 ±
51.5 minutes and the average cross-clamping time under
normothermic and hypothermic conditions is 54 ± 29.1
minutes. Minimizing both periods is in the best interest of
the patient. Considering the extensive use of the literature in
any review manuscript, the true incidence of complications
and the estimate of their impact on the overall outcome
cannot be precisely determined.
Cardiovascular and Hemodynamic Changes
During CPB, perfusion pressures are lower than arterial
pressures under anesthesia. The minimal perfusion pressure
necessary to maintain capillary patency is also a function of
the applied conditions. Hypotension can be associated with
administration of protamine,54 but it is commonly seen after
discontinuation of bypass in dogs.27, 54 Lew et al observed
biphasic hypotensive episodes occurring in the immediate
postoperative period and after 15 hours.27 Compared to
hypothermic CPB, mean arterial pressure is lower upon
discontinuation of the bypass in dogs under normothermic
conditions.28 Diastolic blood pressure after CPB has been
noted to be reduced compared to baseline values and to
remain relatively low in dogs for the first few hours after
conclusion of bypass.33 CPB can also induce acute myocar-
dial edema which is responsible for decreasing left ventric-
ular systolic function in dogs.55 Positive inotropic drugs are
commonly used in people during the postoperative phase in
order to provide necessary cardiovascular support.56 Cen-
tral venous pressures are significantly lower in hypothermic
conditions during bypass.28
Hematologic and Biochemical Changes
Electrolyte changes are commonly observed during and af-
ter CPB in domestic animals. Hematocrit is decreased af-
ter CPB because of hemodilution, hemolysis, coagulopathy,
and blood loss in the postoperative period.27, 29, 33, 36, 45, 57–59
Compared to normothermic conditions, hypothermia in
dogs does not seem to affect hematocrit, hemoglobin, to-
tal protein concentrations, and plasma osmotic pressure,
but it produces a decrease in sodium, chloride, and white
blood cell count during bypass, while the aspartate amino-
transferase (AST) and creatine kinase (CK) increase after
bypass.28 Embolic diseases are often observed in people.59
Hypokalemia is commonly observed during and after CPB,
and can be easily corrected with intravenous administration
of potassium.27–29, 59 The use of high potassium cardiople-
gia solutions has decreased the incidence of hypokalemia
in human patients and it has been responsible occasionally
for intraoperative hyperkalemia.23 Hyperkalemia has been
documented in dogs under CPB and favorably treated with
insulin and dextrose.27 Other electrolytes closely monitored
during CPB in people are calcium and magnesium because
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Table 5 Heparin and Protamine Doses Used with the Activated Clotting Time (ACT) Values Obtained after Heparin Administration
Heparin ACT (seconds) Protamine References
0.35–0.45 mg/kg Pullen et al51
1.5 mg/kg 240–360 seconds7 Breznock and colleagues7,42
10,000 U 10.5 mg10 Breznock and colleagues10,73
100 U/kg >480 seconds70 Tanaka and colleagues3,9,68,70,72,76,78
>400 seconds3,9,76
100 U/kg + 50 U/kg/h NA 0.75 mg/kg Akkerman et al78
100 U/kg + 75 U/kg/h NA Rohn et al55
2 mg/kg NA 5 mg/kg Shiang et al36
2.5 mg/kg >600 (5–6 times from pre bypass)4 1.4 dose of heparin4,5 Behr and colleagues4,5
8645
200 U/kg >400 seconds Soda et al6
250 U/kg NA 10 mg/1000 U heparin Boggs et al58
1 mg/10 U heparin
3 mg/kg >480 seconds20,57,61 1 mg/mg heparin20,57 Martin and colleagues11,12,33,43,54,66
>400 seconds45 0.8–1.2 mg/mg heparin61,67
300 U/kg >450 seconds78 1.3–1.5 mg/100 U heparin,12,64 Monnet and colleagues8,13,15,27,41,75,80
>480 seconds12,50,64,70 0.75 mg/U heparin,8,75
1 mg/100 U heparin,15
1 mg/1000 U heparin80
350 U/kg 42 mg Eyster et al16
400 U/kg >480 seconds 2 mg/kg2 and 4 mg/kg29 Kanemoto and colleagues2,29
4 mg/kg + 2 mg/kg after 30 minutes NA 12 mg/kg slow infusion Rosenkratz et al57
5 mg/kg + 1–2 mg/kg maintenance >450 seconds Van de Linden et al77
Table 6 Complications Observed During Bypass
Complications Timing Possible mechanism Treatment References
Arrhythmia
Ventricular fibrillation Myocardial reperfusion Electroconversion Monnet and colleagues8,27
Cardiovascular and hemodynamic











After bypass initiation Shibazaki et al28
Hyponatremia Shibazaki et al28
Hypokalemia Shibazaki et al28




Insulin/glucose Lew et al27
Hypochloremia Shibazaki et al28










Tearing of aorta Surgical repair and blood
transfusion
Lew et al27
they are known to decline upon initiation of CPB.60 Cal-
cium may need to be administered upon discontinuation
of CPB. Hypomagnesemia can predispose to cardiac ar-
rhythmia, which can be prevented by using supplemental
magnesium.
Respiratory Function
In dogs, CPB can induce an increase in the postoper-
ative PCO2 and respiratory acidosis which can persist
for hours after extubation and can be corrected with
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bicarbonate and by increasing the tidal volume.32 In pa-
tients undergoing hypothermic CPB (24–26◦C), PO2 and
PCO2 are higher during and after bypass, respectively, when
compared to the normothermic group.28 Respiratory aci-
dosis is often observed during and after bypass, hypother-
mia in dogs seems to induce more pronounced acidosis
particularly upon discontinuation of bypass.28 Respiratory
function can be severely affected if the phrenic nerves get
damaged during surface cooling using ice slush.27
Controversial data exist regarding ventilation during
CPB. The incidence of lung failure after bypass is low in
people (1.7%) but the mortality is high.62 Traditionally,
mechanical ventilation is discontinued during CPB. How-
ever, low tidal volume ventilation during bypass may de-
crease lung injury by lowering reperfusion injury and in-
flammatory response.61, 62 Unfortunately, there is currently
no strong evidence that ventilation during bypass can result
in reduction of respiratory complications in people.63 Con-
tinuous positive airway pressure during CPB has also been
postulated to reduce lung injuries.62
Other Complications
Several other complications directly or indirectly associated
with CPB have been reported in dogs and cats (Table 7).
Neurologic complications (cerebral injury and embolism)
seem to be very common in human patients64, 65 but they are
rarely reported in the veterinary literature.2, 16, 33, 66 Various
renal changes after bypass with hematuria and hemoglobin-
uria were reported and can be expected because of the
hemolysis and the use of anticoagulants. Acute renal fail-
ure is a devastating sequela of CPB in people occurring in
∼5% of patients.67 None of the cases described in the vet-
erinary literature had renal failure, although oliguria and
increased creatinine have been reported.29, 33, 66 Oliguria, se-
vere hypotension, poor perfusion, increased creatinine, and
cross-clamp time should be closely monitored to prevent
acute renal failure after bypass.
Among other findings, it is relevant to note the rare
occurrence of intussusception in both adults and puppies
36 hours after bypass.27, 57 Possible causes are to be found in
hypokalemia, tissue edema, decreased gut perfusion, neu-
trophil activation, and hypoalbuminemia.27
CONCLUSION
In conclusion, CPB in domestic species offers a vari-
ety of challenges and innovative approaches to the well-
established practice of perfusion. Some of the features ob-
served in bypassing dogs and cats are very unique to these
species, but others are common to other species including
people. Further investigation of bypass in dogs and cats can
help to advance the knowledge of bypass techniques and
prevention of possible complications. Evaluation of pre-
cise heparin calculation and reversal is an area of possible
research.
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